Release Date: 25/10/11 17:11 Summary: Strzelecki Withdraws from Heads of Agreement Price Sensitive: Yes Download Document 179.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%